Doctronic vs Armilla AI
Side-by-side comparison of AI visibility scores, market position, and capabilities
Doctronic became the first AI to legally renew prescriptions in the US (190-med formulary, Utah); raised $40M Series B with 300K+ visitors as it expands state by state (March 2026).
About
Doctronic is a US-based AI telehealth company that has built a regulatory-compliant AI platform for medical consultations and prescription services. The company made history by becoming the first AI to legally renew prescriptions in the United States, initially operating in Utah under a pioneering regulatory framework that allows AI-assisted prescribing for a defined formulary of medications. Doctronic's platform enables patients to consult with an AI for common, well-understood health conditions and receive prescriptions for up to 190 medications without requiring a synchronous visit with a human physician.\n\nDoctronic's platform is designed to navigate the complex intersection of AI capability, medical regulation, and patient safety. Its AI conducts structured medical history intake, symptom assessment, and contraindication screening before generating prescription recommendations that are reviewed within a compliance framework. The platform targets patients seeking convenient, affordable access to prescription renewals and routine care for chronic and common conditions—a massive market given the primary care shortage in the United States. Doctronic operates at the forefront of AI in regulated healthcare, demonstrating that AI can deliver clinically appropriate care within legal guardrails.\n\nDoctronic raised a $40M Series B in 2026 to accelerate geographic expansion and broaden its formulary and condition coverage. With over 300,000 visitors to its platform, Doctronic has demonstrated real consumer demand for AI-mediated healthcare access. The company's Utah-first strategy allowed it to build a compliant, proven model before pursuing expansion to additional states with favorable telehealth regulations. As regulatory frameworks for AI in medicine evolve, Doctronic is positioned as a first-mover with a defensible regulatory and clinical knowledge base.
AI quality assurance with insurance-backed warranties from Swiss Re and Greenlight Re; EU AI Act compliance assessments backed by YC and reinsurance partners for high-risk AI deployments.
About
Armilla AI is a third-party AI quality assurance and warranty company that evaluates AI models for organizations deploying AI in regulated or high-stakes contexts — assessing models against EU AI Act and NIST AI Risk Management Framework requirements for risks including bias, hallucination, robustness failures, and adversarial vulnerabilities, then providing performance guarantees backed by insurance coverage from reinsurers Swiss Re, Greenlight Re, and Chaucer. Founded in Toronto, Canada, Armilla raised $6.81 million total including a C$4.5 million seed round in February 2024 from Mistral Venture Partners, MS&AD Ventures, Y Combinator, and its reinsurance partners.\n\nArmilla's model is unique in the AI governance market — rather than just providing compliance reports, Armilla backs its assessments with insurance warranty products. An enterprise deploying a third-party AI model can purchase an Armilla warranty that pays out if the model performs differently than assessed (fails on bias, accuracy, or robustness metrics), transferring AI performance risk to insurance markets that can price and distribute it. This insurance mechanism creates financial accountability for AI quality claims that audit reports alone don't provide.\n\nIn 2025, Armilla competes in the AI governance, risk, and compliance market with Credo AI, Arthur AI, and AI audit firms for enterprise AI risk assessment and compliance tools. The EU AI Act, fully applicable by August 2025 for high-risk AI systems, is driving enterprise compliance urgency — companies deploying AI in hiring, credit scoring, healthcare, and other regulated contexts need third-party conformity assessments. Armilla's insurance-backed warranty differentiates its offering from pure advisory competitors. The reinsurer backing (Swiss Re, Greenlight Re, Chaucer) provides both capital credibility and distribution through insurance broker channels. The 2025 strategy focuses on growing EU AI Act compliance assessments and expanding the warranty product coverage to more AI deployment use cases.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.